Celecoxib 200 MG Oral Capsule — RxCUI 205323
RxNorm drug concept · Semantic clinical drug
RxCUI 205323
Semantic clinical drug · SCD
● Current RxNorm concept 185 FDA products
573 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI205323
Official nameCelecoxib 200 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped185
Package NDCs mapped573
Reported Medicaid activity (SDUD)1,201,529 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Celecoxib: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Celecoxib is used for several different conditions depending on the form you have. The capsules treat arthritis pain (osteoarthritis, rheumatoid arthritis, ankylosing spondylitis),...
- What conditions is celecoxib actually used for?
- It depends on which form you have. Regular celecoxib capsules at lower doses can be taken with or without food. At higher doses, taking them with food actually helps your body abso...
- Should I take celecoxib with food or on an empty stomach?
🕸️ Concept Web — How Celecoxib 200 MG Oral Capsule Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Celecoxib 200 MG Oral Capsule
RxCUI 205323 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Celecoxib
140587IN
-
Celecoxib
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Celebrex
215927BN
-
Celebrex
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Celecoxib Oral Capsule
371343SCDF -
Celecoxib Oral Product
1161223SCDG -
Celecoxib Pill
1161224SCDG -
Celecoxib Oral Capsule [Celebrex]
366443SBDF -
Celebrex Oral Product
1166198SBDG -
Celebrex Pill
1166199SBDG -
Oral Capsule
316965DF -
Oral Product
1151131DFG - +1 more in this family
-
Celecoxib Oral Capsule
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Celecoxib 200 MG
315604SCDC -
Celecoxib 200 MG Oral Capsule [Celebrex]
213469SBD -
Celecoxib 200 MG [Celebrex]
573357SBDC
-
Celecoxib 200 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Celecoxib 200 MG
SCDC · 315604 -
Celecoxib Oral Capsule
SCDF · 371343 -
Celecoxib Oral Product
SCDG · 1161223 -
Celecoxib Pill
SCDG · 1161224
Brand-Name Concepts
-
Celecoxib 200 MG Oral Capsule [Celebrex]
SBD · 213469 -
Celecoxib 200 MG [Celebrex]
SBDC · 573357 -
Celecoxib Oral Capsule [Celebrex]
SBDF · 366443 -
Celebrex Oral Product
SBDG · 1166198 -
Celebrex Pill
SBDG · 1166199 -
Celebrex
BN · 215927
📦 FDA Products & Package NDCs
185 products · 573 package NDCs
573 package NDCs map to RxCUI 205323 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 72162-2357-05 | 500 CAPSULE in 1 BOTTLE (72162-2357-5) | CELECOXIB | Bryant Ranch Prepack | 2020-09-03 |
| 72162-2380-01 | 100 CAPSULE in 1 BOTTLE (72162-2380-1) | CELECOXIB | Bryant Ranch Prepack | 2024-08-15 |
| 72162-2380-05 | 500 CAPSULE in 1 BOTTLE (72162-2380-5) | CELECOXIB | Bryant Ranch Prepack | 2024-08-15 |
| 72162-2421-01 | 100 CAPSULE in 1 BOTTLE (72162-2421-1) | Celecoxib | Bryant Ranch Prepack | 2024-11-11 |
| 72162-2421-05 | 500 CAPSULE in 1 BOTTLE (72162-2421-5) | Celecoxib | Bryant Ranch Prepack | 2024-11-11 |
| 72162-2489-01 | 100 CAPSULE in 1 BOTTLE (72162-2489-1) | celecoxib | Bryant Ranch Prepack | 2025-05-14 |
| 72162-2489-05 | 500 CAPSULE in 1 BOTTLE (72162-2489-5) | celecoxib | Bryant Ranch Prepack | 2025-05-14 |
| 72189-0360-10 | 10 CAPSULE in 1 BOTTLE (72189-360-10) | Celecoxib | DirectRx | 2022-06-08 |
| 72189-0360-30 | 30 CAPSULE in 1 BOTTLE (72189-360-30) | Celecoxib | DirectRx | 2022-06-08 |
| 72189-0360-42 | 42 CAPSULE in 1 BOTTLE (72189-360-42) | Celecoxib | DirectRx | 2022-06-08 |
| 72189-0360-60 | 60 CAPSULE in 1 BOTTLE (72189-360-60) | Celecoxib | DirectRx | 2022-06-08 |
| 72189-0360-90 | 90 CAPSULE in 1 BOTTLE (72189-360-90) | Celecoxib | DirectRx | 2022-06-08 |
| 72241-0022-03 | 60 CAPSULE in 1 BOTTLE (72241-022-03) | Celecoxib | Modavar Pharmaceuticals LLC | 2021-08-20 |
| 72241-0022-11 | 1000 CAPSULE in 1 BOTTLE (72241-022-11) | Celecoxib | Modavar Pharmaceuticals LLC | 2021-08-20 |
| 72241-0023-03 | 60 CAPSULE in 1 BOTTLE (72241-023-03) | Celecoxib | Modavar Pharmaceuticals LLC | 2021-08-23 |
| 72241-0023-05 | 100 CAPSULE in 1 BOTTLE (72241-023-05) | Celecoxib | Modavar Pharmaceuticals LLC | 2021-08-23 |
| 72241-0023-10 | 500 CAPSULE in 1 BOTTLE (72241-023-10) | Celecoxib | Modavar Pharmaceuticals LLC | 2021-08-23 |
| 72241-0023-11 | 1000 CAPSULE in 1 BOTTLE (72241-023-11) | Celecoxib | Modavar Pharmaceuticals LLC | 2021-08-23 |
| 72241-0024-03 | 60 CAPSULE in 1 BOTTLE (72241-024-03) | Celecoxib | Modavar Pharmaceuticals LLC | 2021-08-23 |
| 72241-0024-05 | 100 CAPSULE in 1 BOTTLE (72241-024-05) | Celecoxib | Modavar Pharmaceuticals LLC | 2021-08-23 |
| 72241-0024-10 | 500 CAPSULE in 1 BOTTLE (72241-024-10) | Celecoxib | Modavar Pharmaceuticals LLC | 2021-08-23 |
| 72241-0024-11 | 1000 CAPSULE in 1 BOTTLE (72241-024-11) | Celecoxib | Modavar Pharmaceuticals LLC | 2021-08-23 |
| 72241-0025-03 | 60 CAPSULE in 1 BOTTLE (72241-025-03) | Celecoxib | Modavar Pharmaceuticals LLC | 2021-08-23 |
| 72241-0025-20 | 600 CAPSULE in 1 BOTTLE (72241-025-20) | Celecoxib | Modavar Pharmaceuticals LLC | 2021-08-23 |
| 72789-0259-14 | 14 CAPSULE in 1 BOTTLE, PLASTIC (72789-259-14) | Celecoxib | PD-Rx Pharmaceuticals, Inc. | 2022-07-18 |
| 72789-0259-30 | 30 CAPSULE in 1 BOTTLE, PLASTIC (72789-259-30) | Celecoxib | PD-Rx Pharmaceuticals, Inc. | 2022-07-08 |
| 72789-0259-60 | 60 CAPSULE in 1 BOTTLE, PLASTIC (72789-259-60) | Celecoxib | PD-Rx Pharmaceuticals, Inc. | 2022-09-20 |
| 75834-0236-05 | 500 CAPSULE in 1 BOTTLE (75834-236-05) | CELECOXIB | NIVAGEN PHARMACEUTICALS, INC. | 2020-09-03 |
| 75834-0236-11 | 100 CAPSULE in 1 BLISTER PACK (75834-236-11) | CELECOXIB | NIVAGEN PHARMACEUTICALS, INC. | 2020-09-03 |
| 75834-0236-60 | 60 CAPSULE in 1 BOTTLE (75834-236-60) | CELECOXIB | NIVAGEN PHARMACEUTICALS, INC. | 2020-09-03 |
| 75834-0237-01 | 100 CAPSULE in 1 BOTTLE (75834-237-01) | CELECOXIB | NIVAGEN PHARMACEUTICALS, INC. | 2020-09-03 |
| 75834-0237-05 | 500 CAPSULE in 1 BOTTLE (75834-237-05) | CELECOXIB | NIVAGEN PHARMACEUTICALS, INC. | 2020-09-03 |
| 75834-0237-11 | 100 CAPSULE in 1 BLISTER PACK (75834-237-11) | CELECOXIB | NIVAGEN PHARMACEUTICALS, INC. | 2020-09-03 |
| 75834-0238-01 | 100 CAPSULE in 1 BOTTLE (75834-238-01) | CELECOXIB | NIVAGEN PHARMACEUTICALS, INC. | 2020-09-03 |
| 75834-0238-05 | 500 CAPSULE in 1 BOTTLE (75834-238-05) | CELECOXIB | NIVAGEN PHARMACEUTICALS, INC. | 2020-09-03 |
| 75834-0238-11 | 100 CAPSULE in 1 BLISTER PACK (75834-238-11) | CELECOXIB | NIVAGEN PHARMACEUTICALS, INC. | 2020-09-03 |
| 75834-0239-05 | 500 CAPSULE in 1 BOTTLE (75834-239-05) | CELECOXIB | NIVAGEN PHARMACEUTICALS, INC. | 2020-09-03 |
| 75834-0239-11 | 100 CAPSULE in 1 BLISTER PACK (75834-239-11) | CELECOXIB | NIVAGEN PHARMACEUTICALS, INC. | 2020-09-03 |
| 75834-0239-60 | 60 CAPSULE in 1 BOTTLE (75834-239-60) | CELECOXIB | NIVAGEN PHARMACEUTICALS, INC. | 2020-09-03 |
| 76420-0009-01 | 1 CAPSULE in 1 BOTTLE (76420-009-01) | celecoxib | Asclemed USA, Inc. | 2020-01-18 |
| 76420-0009-07 | 7 CAPSULE in 1 BOTTLE (76420-009-07) | celecoxib | Asclemed USA, Inc. | 2020-01-18 |
| 76420-0009-14 | 14 CAPSULE in 1 BOTTLE (76420-009-14) | celecoxib | Asclemed USA, Inc. | 2023-09-02 |
| 76420-0009-20 | 20 CAPSULE in 1 BOTTLE (76420-009-20) | celecoxib | Asclemed USA, Inc. | 2023-09-02 |
| 76420-0009-30 | 30 CAPSULE in 1 BOTTLE (76420-009-30) | celecoxib | Asclemed USA, Inc. | 2020-01-18 |
| 76420-0009-60 | 60 CAPSULE in 1 BOTTLE (76420-009-60) | celecoxib | Asclemed USA, Inc. | 2020-06-04 |
| 76420-0009-90 | 90 CAPSULE in 1 BOTTLE (76420-009-90) | celecoxib | Asclemed USA, Inc. | 2023-09-02 |
| 76420-0714-01 | 1 CAPSULE in 1 BOTTLE (76420-714-01) | Celecoxib | Asclemed USA, Inc. | 2024-05-10 |
| 76420-0714-05 | 500 CAPSULE in 1 BOTTLE (76420-714-05) | Celecoxib | Asclemed USA, Inc. | 2024-05-10 |
| 76420-0714-07 | 7 CAPSULE in 1 BOTTLE (76420-714-07) | Celecoxib | Asclemed USA, Inc. | 2024-05-10 |
| 76420-0714-10 | 100 CAPSULE in 1 BOTTLE (76420-714-10) | Celecoxib | Asclemed USA, Inc. | 2024-05-10 |
Observed labelers:
Asclemed USA, Inc. (76) ·
Bryant Ranch Prepack (58) ·
Torrent Pharmaceuticals Limited (26) ·
Proficient Rx LP (22) ·
Alembic Pharmaceuticals Inc. (20) ·
Alembic Pharmaceuticals Limited (20)
· +51 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.